Literature DB >> 25239674

How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C.

Rebecca L Morgan1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25239674     DOI: 10.1007/s00535-014-0990-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  6 in total

1.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

Authors: 
Journal:  J Hepatol       Date:  2013-12-09       Impact factor: 25.083

2.  Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes.

Authors:  Naoki Yamashita; Aritsune Ohho; Akihiro Yamasaki; Miho Kurokawa; Kazuhiro Kotoh; Eiji Kajiwara
Journal:  J Gastroenterol       Date:  2013-12-08       Impact factor: 7.527

Review 3.  The rapid evolution of treatment strategies for hepatitis C.

Authors:  Andrew J Muir
Journal:  Am J Gastroenterol       Date:  2014-04-15       Impact factor: 10.864

Review 4.  Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.

Authors:  Rebecca L Morgan; Brittney Baack; Bryce D Smith; Anthony Yartel; Marc Pitasi; Yngve Falck-Ytter
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

5.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 6.  Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir.

Authors:  John N Gaetano
Journal:  Drug Healthc Patient Saf       Date:  2014-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.